BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:06 PM
 | 
Jul 20, 2009
 |  BC Extra  |  Company News

FDA accepts APF530 NDA

FDA accepted for review an NDA from A.P. Pharma Inc. (NASDAQ:APPA) for APF530 to prevent chemotherapy-induced nausea...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >